Clinical Research Directory

Inclusion Criteria: 1. A diagnosis of recurrent symptomatic paroxysmal AF 2. Failure or intolerance of at least one Class I or III antiarrhythmic drug (including sotalol) 3. Patient is ≥ 18 years of age 4. Planned procedure for the treatment of AF using commercially available DiamondTemp™ Ablation System 5. Patient is willing and able to provide written informed consent 6. Patient is willing and able to comply with study requirements Exclusion Criteria: 1. Prior persistent AF (continuous AF that is sustained \>7 days) 2. Patient with life expectancy that makes it unlikely 36 months of follow-up will be completed. 3. Current or anticipated participation in any other clinical trial of a drug, device or biologic during the duration of this study not pre-approved by Medtronic 4. Patients with contraindications to a Holter monitor 5. Unwilling or unable to comply fully with study procedures and follow-up